Fintel reports that on January 9, 2025, Barclays downgraded their outlook for Harmonic (NasdaqGS:HLIT) from Overweight to ...

On Wednesday, Barclays PLC (BCS) stock saw a decline, ending the day at $13.19 which represents a decrease of $-0.06 or -0.45% from the prior close of $13.25. The stock opened at $13.01 and touched a ...

Barclays raised the firm’s price target on Ulta Beauty (ULTA) to $445 from $410 and keeps an Equal Weight rating on the shares. The company’s ...

US-based Lantheus Holdings becomes largest shareholder in Radiopharm Theranostics after US$5 million private placement.

A star fund manager has dumped his stake in the owner of Guinness and Johnnie Walker amid fears that the rise of weight-loss ...

Investing.com -- Barclays (LON: BARC) has upgraded Partners Group to "overweight,” reflecting increased confidence in its ...

Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

Barclays PLC lowered its position in shares of Brookfield Asset Management Ltd. (NYSE:BAM – Free Report) (TSE:BAM.A) by 24.8% in the 3rd quarter, HoldingsChannel.com reports. The institutional ...

Barclays PLC raised its holdings in Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) by 311.2% during the third quarter, according to its most recent filing with the Securities and Exchange ...

Fintel reports that on January 8, 2025, Barclays upgraded their outlook for Tapestry (NYSE:TPR) from Equal-Weight to ...

Donald Trump Jr landed in Greenland on a 'personal day-trip' hours after his father repeated his wish for the US to take ...

Bank of America is the #2 bank in the US but faces a number of headwinds in the next half decade for its stock to match its ...